These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 27535254)
1. Hyperuricemia in Tendons. Andia I; Abate M Adv Exp Med Biol; 2016; 920():123-32. PubMed ID: 27535254 [TBL] [Abstract][Full Text] [Related]
2. Tendon involvement in the feet of patients with gout: a dual-energy CT study. Dalbeth N; Kalluru R; Aati O; Horne A; Doyle AJ; McQueen FM Ann Rheum Dis; 2013 Sep; 72(9):1545-8. PubMed ID: 23334212 [TBL] [Abstract][Full Text] [Related]
3. Differences in MSU-induced superoxide responses by neutrophils from gout subjects compared to healthy controls and a role for environmental inflammatory cytokines and hyperuricemia in neutrophil function and survival. Martin WJ; Grainger R; Harrison A; Harper JL J Rheumatol; 2010 Jun; 37(6):1228-35. PubMed ID: 20395644 [TBL] [Abstract][Full Text] [Related]
4. Clinical features of gout. Grassi W; De Angelis R Reumatismo; 2012 Jan; 63(4):238-45. PubMed ID: 22303530 [TBL] [Abstract][Full Text] [Related]
5. [New knowledge on the pathophysiology and therapy of gout]. So A Z Rheumatol; 2007 Nov; 66(7):562, 564-7. PubMed ID: 17924125 [TBL] [Abstract][Full Text] [Related]
6. Definition of hyperuricemia and gouty conditions. Bardin T; Richette P Curr Opin Rheumatol; 2014 Mar; 26(2):186-91. PubMed ID: 24419750 [TBL] [Abstract][Full Text] [Related]
7. [Physiology and dynamics of uric acid in hyperuricemia]. Takagi K; Nakamura T; Ueda T Nihon Rinsho; 2008 Apr; 66(4):669-74. PubMed ID: 18409512 [TBL] [Abstract][Full Text] [Related]
9. Pathophysiology of Gout. Narang RK; Dalbeth N Semin Nephrol; 2020 Nov; 40(6):550-563. PubMed ID: 33678310 [TBL] [Abstract][Full Text] [Related]
10. Soluble Uric Acid Is an Intrinsic Negative Regulator of Monocyte Activation in Monosodium Urate Crystal-Induced Tissue Inflammation. Ma Q; Honarpisheh M; Li C; Sellmayr M; Lindenmeyer M; Böhland C; Romagnani P; Anders HJ; Steiger S J Immunol; 2020 Aug; 205(3):789-800. PubMed ID: 32561569 [TBL] [Abstract][Full Text] [Related]
11. [Risk factors and diagnostic value for ultrasound-detected tendon monosodium urate crystal deposition in patients with gout]. Wang Y; Deng XR; Ji LL; Zhang XH; Geng Y; Zhang ZL Beijing Da Xue Xue Bao Yi Xue Ban; 2020 Dec; 53(1):143-149. PubMed ID: 33550349 [TBL] [Abstract][Full Text] [Related]
12. Study on the anti-gout activity of chlorogenic acid: improvement on hyperuricemia and gouty inflammation. Meng ZQ; Tang ZH; Yan YX; Guo CR; Cao L; Ding G; Huang WZ; Wang ZZ; Wang KD; Xiao W; Yang ZL Am J Chin Med; 2014; 42(6):1471-83. PubMed ID: 25384446 [TBL] [Abstract][Full Text] [Related]
13. [Recent advances in the pathophysiology of hyperuricemia and gout]. So A Rev Med Suisse; 2007 Mar; 3(103):720, 722-4. PubMed ID: 17458149 [TBL] [Abstract][Full Text] [Related]
14. Soluble monosodium urate, but not its crystal, induces toll like receptor 4-dependent immune activation in renal mesangial cells. Xiao J; Fu C; Zhang X; Zhu D; Chen W; Lu Y; Ye Z Mol Immunol; 2015 Aug; 66(2):310-8. PubMed ID: 25909495 [TBL] [Abstract][Full Text] [Related]
15. Overview of Serum Uric Acid Treatment Targets in Gout: Why Less Than 6 mg/dL? Ruoff G; Edwards NL Postgrad Med; 2016 Sep; 128(7):706-15. PubMed ID: 27558643 [TBL] [Abstract][Full Text] [Related]
16. [Historical review of gout and hyperuricemia investigations]. Nakamura T Nihon Rinsho; 2008 Apr; 66(4):624-35. PubMed ID: 18409506 [TBL] [Abstract][Full Text] [Related]